Zr89 + PET Companion Trial

Clinical trial NCT05279027 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05279027
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2022-03-08
Primary completion: 2026-07-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.